Document is current
Any future updates will be listed below
-
Authors
Sawada, Masashi
Kasuga, Akiyoshi http://orcid.org/0000-0002-2234-1135
Mie, Takafumi
Furukawa, Takaaki
Taniguchi, Takanobu
Fukuda, Koshiro
Yamada, Yuto
Takeda, Tsuyoshi
Kanata, Ryo
Matsuyama, Masato
Sasaki, Takashi
Ozaka, Masato
Sasahira, Naoki
- License Information
-
More Information
Article History
Received: 16 March 2020
Accepted: 10 May 2020
First Online: 20 May 2020
Ethics approval and consent to participate
: This study was approved by the Institutional Review Board of the Cancer Institute Hospital of Japanese Foundation for Cancer Research (No. 2018–1208) and was conducted in accordance with the Declaration of Helsinki. All patients provided written informed consent.
: Not applicable.
: All authors declare no conflicts of interests for this article. Conflicts of interests outside this work are as follows; Naoki Sasahira received honoraria from Toshiba, Cook Medical and Boston Scientific and research funding from Zeria, Eisai, Kyowa Hakko Kirin, Baxalta and Taiho Pharmaceutical. Masato Ozaka received honoraria from Taiho Pharmaceutical, Yakult, Bayer, Pfizer, Novartis, Takeda Pharmaceutical Company Limited, Eisai, EA pharma and Mitsubishi Tanabe Pharma Corporation and research funding from Merck & Co., Inc., Incyte, ASLAN Pharmaceuticals, Taiho Pharmaceutical and Yakult. Takashi Sasaki received honoraria from Taiho Pharmaceutical, Eisai, Boston Scientific Japan, Century Medical Inc. and Cook Japan.
